Left ventricular assist devices: Physiologic assessment using echocardiography for management and optimization

Farouk Mookadam, Christopher B. Kendall, Raymond K. Wong, Anantharam Kalya, Tahlil Warsame, Francisco A. Arabia, Joan Lusk, Sherif Moustafa, Eric Steidley, Nishath Quader, Krishnaswamy Chandrasekaran

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

Left ventricular assist devices (LVAD) are being deployed increasingly in patients with severe left ventricular dysfunction and medically refractory congestive heart failure of any etiology. The United States Food and Drug Administration (FDA) recently approved the use of the Thoratec Heartmate II (Thoratec Corporation, Pleasanton, CA, USA) for outpatient use. Echocardiography is fundamental during each stage of patient management, pre-LVAD placement, during LVAD placement, for postoperative LVAD optimization and long-term follow-up. We present a pragmatic and systematic echocardiographic approach that serves as a guide for the management of left ventricular assist devices.

Original languageEnglish
Pages (from-to)335-345
Number of pages11
JournalUltrasound in Medicine and Biology
Volume38
Issue number2
DOIs
StatePublished - Feb 1 2012
Externally publishedYes

Keywords

  • 2-dimensional echocardiography
  • Congestive heart failure
  • LVAD physiology and optimization
  • Left ventricular assist devices

Fingerprint Dive into the research topics of 'Left ventricular assist devices: Physiologic assessment using echocardiography for management and optimization'. Together they form a unique fingerprint.

  • Cite this

    Mookadam, F., Kendall, C. B., Wong, R. K., Kalya, A., Warsame, T., Arabia, F. A., Lusk, J., Moustafa, S., Steidley, E., Quader, N., & Chandrasekaran, K. (2012). Left ventricular assist devices: Physiologic assessment using echocardiography for management and optimization. Ultrasound in Medicine and Biology, 38(2), 335-345. https://doi.org/10.1016/j.ultrasmedbio.2011.11.009